Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
European Journal of Radiology
|
September 29, 2012
Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma
Gilad Liberman, Yoram Louzoun, Orna Aizenstein, et al.
Journal of Neuro-Oncology
|
July 6, 2016
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
Deborah T Blumenthal, Michal Yalon, Gilad W Vainer, et al.
Neuro-Oncology Advances
|
March 4, 2026
Rethinking treatment de-escalation in elderly glioblastoma: Lessons from a multicenter real-world cohort
Orit Furman, Eva Falah, Inbar Dvir, et al.
International Journal of Computer Assisted Radiology and Surgery
|
December 23, 2017
MRI radiomics analysis of molecular alterations in low-grade gliomas
Ben Shofty, Moran Artzi, Dafna Ben Bashat, et al.
Journal of Neuro-Oncology
|
May 6, 2015
Calcification in high grade gliomas treated with bevacizumab
Deborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Radiology
|
November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study
Daniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastoma
Tal Shahar, Erez Nossek, David M Steinberg, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Journal of Neuro-Oncology
|
January 15, 2018
Neurologic complications of immune checkpoint inhibitors
Avi Fellner, Chen Makranz, Michal Lotem, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
European Journal of Radiology
|
September 29, 2012
Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma
Gilad Liberman, Yoram Louzoun, Orna Aizenstein, et al.
Journal of Neuro-Oncology
|
July 6, 2016
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors
Deborah T Blumenthal, Michal Yalon, Gilad W Vainer, et al.
Neuro-Oncology Advances
|
March 4, 2026
Rethinking treatment de-escalation in elderly glioblastoma: Lessons from a multicenter real-world cohort
Orit Furman, Eva Falah, Inbar Dvir, et al.
International Journal of Computer Assisted Radiology and Surgery
|
December 23, 2017
MRI radiomics analysis of molecular alterations in low-grade gliomas
Ben Shofty, Moran Artzi, Dafna Ben Bashat, et al.
Journal of Neuro-Oncology
|
May 6, 2015
Calcification in high grade gliomas treated with bevacizumab
Deborah T Blumenthal, Orna Aisenstein, Idan Ben-Horin, et al.
Radiology
|
November 28, 2018
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study
Daniel P Barboriak, Zheng Zhang, Pratikkumar Desai, et al.
Journal of Neuro-Oncology
|
October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma
Mark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastoma
Tal Shahar, Erez Nossek, David M Steinberg, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Journal of Neuro-Oncology
|
January 15, 2018
Neurologic complications of immune checkpoint inhibitors
Avi Fellner, Chen Makranz, Michal Lotem, et al.
Page
of 5